Figures
Abstract
RNase P is an essential enzyme that processes 5' end leader sequence of pre-tRNA to generate mature tRNA. The bacterial RNase Ps contain a RNA subunit and one protein subunit, where the RNA subunit contains the catalytic activity. The protein subunit which lacks any catalytic activity, relaxes the ionic requirements for holoenzyme reaction and is indispensable for pre-tRNA cleavage in vivo. In the current study, we reconstituted the M. tuberculosis RNase P holoenzyme in vitro. We prepared the RNase P protein through two different strategies that differ in the conditions under which the recombinant M. tuberculosis protein, expressed in E. coli was purified. The mycobacterial RNase P protein which was purified under native conditions subsequent to isolation from inclusion bodies and in vitro renaturation, was capable of cleaving pre-tRNA specifically without the requirement of RNase P RNA. However, the preparation that was purified under denaturing conditions and refolded subsequently lacked any inherent pre-tRNA processing activity and cleaved the substrate only as a component of the holoenzyme with the RNA subunit. We found that the two RNase P protein preparations attained alternative conformations and differed with respect to their stability as well.
Citation: Singh A, Ubaid-ullah S, Ramteke AK, Batra JK (2016) Influence of Conformation of M. tuberculosis RNase P Protein Subunit on Its Function. PLoS ONE 11(4): e0153798. https://doi.org/10.1371/journal.pone.0153798
Editor: Seyed Ehtesham Hasnain, Indian Institute of Technology Delhi, INDIA
Received: February 10, 2016; Accepted: April 4, 2016; Published: April 18, 2016
Copyright: © 2016 Singh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This work was supported by grants to the National Institute of Immunology from the Department of Biotechnology, Government of India.
Competing interests: The authors have declared that no competing interests exist.
Introduction
In a cell, transfer RNA (tRNA) acts as an adaptor between the coding sequence in messenger RNA and amino acid sequence in proteins [1]. The tRNA must be folded to the correct ‘L-shaped’ tertiary structure in order to participate in protein translation [2]. After transcription, tRNA molecules have extra sequences at 5’ and 3’ ends, referred to as 5’ leader and 3’ trailer, respectively. The tRNA along with its extra sequences is denoted as precursor tRNA (pre-tRNA) [3]. These extra sequences in the pre-tRNA must be removed to form a mature tRNA product that can attain correct conformational shape and take part in the protein synthesis process. This process of removal of extra sequences is referred to as pre-tRNA processing. Several enzymes are involved in this task in vivo [4]. The 3’ trailer sequence is processed by enzymes like RNase D, E, F, Z, etc. [5,6]. The 5’ leader sequence is removed by a single endonuclease called RNase P [7].
RNase P is a ribonucleoprotein complex consisting of a catalytic RNA component and one or more protein subunits, depending on the organism [8,9]. The RNA component is the catalytic component of the holoenzyme that contains the active site where phosphodiester bond cleavage takes place to generate mature tRNA product from the pre-tRNA molecule [10]. The RNA component alone can process pre-tRNA, without the RNase P protein, under high ionic concentrations in vitro [11]. In vivo, the protein component is indispensable for RNase P activity [12]. The bacterial RNase P holoenzyme is composed of an RNA subunit of 330–420 nucleotides and a protein subunit of around 120 amino acids [13]. The archaeal and eukaryotic RNase P holoenzymes consist of one RNA subunit, but the number of protein subunits varies. While in archaea five protein subunits have been recognized, in eukaryotes nine to ten protein subunits have been reported [14,15].
The protein component of RNase P forms a functional complex with the RNA subunit. The protein subunit in RNase P holoenzyme alters the recognition of the pre-tRNA in many ways. This is evident from the fact that the B. subtilis holoenzyme binds pre-tRNA more tightly than tRNA, whereas the RNA component binds product more tightly [16]. Interactions of RNase P RNA with the 21 to 25 nucleotides long leader sequence and the T stem of pre-tRNA are altered in the presence of the protein component [17], which also lowers the required concentration of magnesium for efficient catalysis [18]. These functional changes in the holoenzyme may be caused by direct contacts between the substrate and the protein and/or by a protein-induced conformational change in the RNA. In E. coli RNase P, it is shown that the protein subunit's binding site on the RNA component is neither close to the active site nor close to the substrate binding site indicating that the binding of protein might induce some conformational changes in RNA that lead to the enhanced activity of holoenzyme compared to RNA alone [19]. In B. subtilis RNase P, although no cross-linking contacts are observed between protein and the mature sequence of pre-tRNA, RNase P protein contacts the single-stranded leader sequence of pre-tRNA [20]. The cross-linking data confirm that the RNase P protein is involved in substrate binding. The protein components of various bacterial RNase Ps have two conserved motifs, namely the RNR motif and Central Cleft, which are respectively involved in protein's interaction with the RNA component and substrate [13,16].
Like in other bacteria, M. tuberculosis RNase P is also composed of one RNA and one protein subunit. The RNR motif and central cleft are generally conserved in the mycobacterial enzymes, though it also contains few unique residues in these regions. Earlier, we have functionally characterized the RNase P enzyme of M. tuberculosis [21]. The protein and RNA components of M. tuberculosis RNase P were produced in E. coli in vitro and reconstituted to generate a functionally active enzyme [21]. During our earlier study it was observed that the protein component of M. tuberculosis RNase P, made under certain conditions, was able to process pre-tRNA independently. In this study, the mycobacterial RNase P protein was recombinantly produced in E. coli by two different strategies. One of the two protein preparations manifested pre-tRNA processing activity in the absence of RNA component, which is unusual for a bacterial RNase P. The study demonstrates that the RNase P protein component of M. tuberculosis is capable of attaining a conformation which imparts catalytic activity to the protein.
Materials and Methods
Expression and Purification of M. tuberculosis RNase Protein Component P in E. coli
The gene encoding RNase P protein component is annotated as rnpA in M. tuberculosis genome. The DNA encoding the protein component of mycobacterial RNase P was cloned and expressed in E. coli as described earlier [21]. The E. coli strain BL21 (λDE3) (New England Biolabs, USA) was transformed with the expression vector pVex11 containing the rnpA gene. The culture was grown in superbroth medium containing 0.1 mg/ml ampicillin at 37°C with shaking. The culture was induced with 1 mM IPTG at A600 of 1–1.2. The cells were harvested 2 hours after induction by centrifugation at 4000xg at 4°C for 15 minutes. The recombinant protein was localized in the inclusion bodies.
Two different protocols were subsequently followed to denature, renature and purify the recombinant protein from the inclusion bodies. In the first protocol, which was used in our earlier study [21], the purified inclusion bodies were dissolved in Buffer A that had 8 M urea in 20 mM Tris-Cl, pH 8. The denatured protein was loaded on a SP-sepharose, cation exchange column equilibrated with Buffer A. Extensive washing of the column was done with 10 column volumes. Elution of the bound protein was done using a gradient 0 to 2 M sodium chloride in Buffer A. The fractions collected were run analyzed by SDS-PAGE and those containing the RNase P protein were pooled. Step-wise dialysis of the pooled protein was performed in order to gradually remove urea completely and renature the protein. The protein was finally brought in 20 mM Tris-Cl, pH 8. This protein preparation is denoted as ''RNase P-U protein'' in the manuscript.
In the second protocol, the inclusion bodies were dissolved in Buffer B containing 6M guanidine-hydrochloride in 1M Tris-Cl, 0.5 M EDTA, pH 8. The denatured protein was oxidized using 0.9 mM glutathione and kept for renaturation by 100-fold dilution in Buffer C containing 0.1 M Tris-Cl, pH 8, 0.5 M L-arginine and 2 mM EDTA, for 36 hours. The renatured protein was dialyzed against 0.1 M urea in MES buffer, pH 6. The protein was then subjected to cation-exchange chromatography on a SP sepharose column. The bound protein was eluted using a gradient of 0 to 2 M sodium chloride in MES buffer, pH 6. The fractions were analyzed by SDS-PAGE and those containing the RNase P protein were pooled. The protein was subjected to size-exclusion chromatography on Superose 12 column in Phosphate buffered saline, pH 7.4. The fractions containing the RNase P protein were collected. This protein preparation is denoted as ''RNase P-G'' in the manuscript.
N-terminal sequencing confirmed the authenticity of the two protein preparations. The concentration of the purified protein was estimated by Bradford's method [22]. SDS-PAGE was performed by Laemmli’s method [23] to analyze the purity of proteins.
CD Spectral Analysis of Proteins
Far-UV (250–200 nm) and Near-UV (320–250 nm) CD spectra were measured using a cell of 0.1 cm and 1 cm path-length, respectively in JASCO spectropolarimeter (Model- J815) attached to a peltier temperature controller. The spectra were recorded at a scan rate of 100 nm.min-1. For each spectrum, at least 10 scans were taken. Protein concentration of 12 μM and RNA concentration of 2 μM was used.
Cloning of DNAs Encoding RNA Component of RNase P and Precursor tRNA Alanine of M. tuberculosis
The DNAs encoding RNA component of mycobacterial RNase P and an isoform of alanine tRNA, annotated as AlaU, were cloned in E. coli vectors as described earlier [21]. In vitro transcription was performed, using a modified protocol of Kreig and Melton [24], to make RNase P RNA component and the pre-tRNA substrate [21].
Assay for Enzymatic Activity of RNase P
The reaction to assay the pre-tRNA processing contained 50 mM Tris-Cl pH-7.4, 500 mM ammonium acetate, 10 mM magnesium chloride for RNase P-G holoenzyme, and 50 mM Tris-Cl pH-7.4, 100 mM ammonium acetate, 10 mM magnesium chloride for RNase P-U holoenzyme with indicated concentrations of RNase P RNA and/or protein and labeled substrate pre-tRNAala in 20 μl reaction volume. In case of reactions containing RNase P RNA, it was pre-incubated at 50°C for 30 minutes, followed by cooling to room temperature, and then the protein component was added. The substrate pre-tRNAala was added last. The reaction was kept at 37°C for 10 minutes. A 10% acrylamide gel containing 7 M Urea was used to separate the pre-tRNA substrate and the mature product. The contents of the gel were visualized by autoradiography. The bands on the autoradiogram were quantified densitometrically on an Alpha Imager gel documentation system. The data were processed to obtain relative product formation.
Zymogram Analysis of Proteins
A zymogram analysis was performed as described by Blank et al. [25] to analyze RNase activity in various proteins. Proteins were run on 15% SDS-polyacrylamide gel containing 0.3 mg/ml yeast tRNA under non-reducing conditions. After the electrophoresis, SDS was removed by washing in 25% isopropanol. Gels were incubated at room temperature for 15 minutes and stained for undigested RNA with 0.2% toluidine blue. Appearance of clear zones against a blue background indicates ribonucleolytic activity.
Micrococcal Nuclease and Proteinase K Treatment
A typical reaction mixture to treat RNase P components with micrococcal nuclease (MN) contained 50 mM Tris-HCl buffer, pH 9, 2 mM calcium chloride and 300 U/ml MN as suggested by the manufacturer (Sigma Chemical Company). The reaction was incubated at 37°C for 30 minutes and stopped by addition of 10 mM ethylene glycol tetraacetic acid (EGTA).
The RNase P components were treated with 25 mg/ml Proteinase K (PK) in 50 mM Tris-HCl buffer, pH 8 and 1.5 mM calcium chloride at 37°C for 30 minutes.
After the treatment with nuclease or proteinase, the treated components were assayed for pre-tRNA processing activity using standard conditions of 10 mM magnesium chloride, 100 mM ammonium acetate in 50 mM Tris-HCL pH 7.4 for RNase P-G and RNase P-U proteins; and 500 mM magnesium chloride, 500 mM ammonium acetate in 50 mM Tris-HCl pH 7.4 for RNase P RNA alone, at 37°C for 10 minutes.
Results
Expression of the Components of the RNase P of M. tuberculosis
The DNA encoding RNase P protein component, cloned in expression vector pVex11, was expressed in E. coli BL21 (λDE3) cells. The expressed protein was localized in the inclusion bodies. The protein component of RNase P of M. tuberculosis was further purified from inclusion bodies by two different methods resulting in two protein preparations termed RNase P-U and RNase P-G protein, respectively (Fig 1). The holoenzymes obtained by reconstitution of two proteins with RNase P RNA are termed as RNase P-U holoenzyme and RNase P-G holoenzyme.
The two purified protein preparations of M. tuberculosis RNase P expressed in E. coli were analysed by SDS-polyacrylamide gel electrophoresis on a 14% gel. Molecular weight markers are shown in kDa.
Characterization of Pre-tRNA Cleavage Activity of M. tuberculosis RNase P
The two preparations of the RNase P protein component were analyzed for their effect on the pre-tRNA substrate (Fig 2). The RNase P-G protein was found to cleave the pre-tRNA by itself in a dose dependent manner, whereas the RNase P-U protein did not cleave pre-tRNA at all (Fig 2). RNase P-G protein showed complete processing of pre-tRNA beyond 200 nM concentration of the protein (Fig 2).
The pre-tRNA processing activity with different amounts of RNase P protein preparations alone, in the absence of RNA component, was assayed in 50 mM Tris-HCl (pH 7.4), 10 mM magnesium chloride and 100 mM ammonium acetate. S denotes the substrate alone reaction.
Comparison of Pre-tRNA Processing Activities of RNase P-G Holoenzyme and RNase P-U Holoenzyme
The activity of the holoenzyme complexes reconstituted separately with RNA component and RNase P-U and RNase P-G protein components was checked on pre-tRNA substrate at various concentrations of ammonium acetate (Fig 3). Both holoenzymes showed pre-tRNA processing activity with increasing ammonium acetate concentration (Table 1). The activity of RNase P-G protein alone was inhibited with increasing concentration of ammonium acetate and it had negligible activity at 500 mM ammonium acetate (Fig 3, Table 1). The RNase P-U protein by itself did not show any pre-tRNA cleavage at any ammonium acetate concentration (Fig 3).
The pre-tRNA processing activity of RNase P-G and RNase P-U proteins and their holoenzymes was assayed in the presence of different concentrations of ammonium acetate. To reconstitute the RNase P holoenzyme, 50 nM RNase P RNA and 100 nM RNase P protein were used. For protein alone activity, 100 nM protein was used in the assays.
The activity of holoenzyme complex reconstituted with RNase P-G protein was calculated by subtracting the protein-alone activity from that of the holoenzyme activity for the respective proteins (Table 1). The RNase P-U holoenzyme showed higher pre-tRNA processing than RNase P-G holoenzyme at all concentrations of ammonium acetate (Table 1).
Comparison of Pre-tRNA Processing by RNase P RNA and RNase P-G Protein and Zymogram Analysis of Proteins
One of the reasons for catalytic activity being manifested by RNase P-G protein could be the presence of RNA component of E. coli RNase P which may be co-purifying with the protein. To investigate the possibility of any contaminating RNA in the RNase P-G protein preparation, different combinations of magnesium and ammonium ions were used to assess the pre-tRNA processing by RNase P RNA and RNase P-G protein (Fig 4A). As shown in Fig 4A, RNase P RNA cleaves the pre-tRNA in vitro at high concentrations of magnesium and ammonium ions. On the other hand, RNase P-G protein processed pre-tRNA only at low concentrations of magnesium and ammonium ions, suggesting it to be an activity of the protein (Fig 4A).
A. Indicated concentrations of magnesium and ammonium ions were used to assay the pre-tRNA cleavage by RNase P RNA and RNase P-G protein. The reactions contained 50 nM of RNase P RNA and 100 nM of RNase P-G protein. B. Zymogram analysis of the two protein preparations, albumin and RNase A.
A zymogram analysis of the two protein preparations was done using yeast-tRNA as the substrate to analyze if the RNase P-G protein had a contaminating RNase or the protein itself contained non-specific ribonucleolytic activity. The two RNase P protein preparations and the BSA, taken as negative control did not show any cleavage of yeast tRNA (Fig 4B). RNase A, used as positive control showed efficient digestion of yeast tRNA at as low as 0.1 μg amount (Fig 4B).
Treatment of Components of RNase P with Nuclease and Proteinase K
The RNase P components, RNase P-G and RNase P-U proteins, and RNase P RNA were separately treated with micrococcal nuclease to determine if the protein preparation contained any contaminating RNA component of E. coli. After the treatment, micrococcal nuclease was inactivated by addition of EGTA to the reaction as it requires calcium ions for activity. The components were separately treated with proteinase K also to confirm that the activity seen with RNase P-G protein was within the protein. After treatment with nuclease and proteinase, the treated components were used to assay the pre-tRNA processing activity using standard conditions. The activity of RNase P-G protein alone was abolished upon treatment with proteinase K, however it was unaffected after treatment with micrococcal nuclease (Fig 5). As seen before, RNase P-U protein did not show any activity by itself under any conditions (Fig 5). The RNase P RNA alone activity was abolished upon treatment with micrococcal nuclease, and remained unaffected after treatment with proteinase K (Fig 5). When the holoenzymes, reconstituted with RNA component and RNase P-G and PU proteins were treated with proteinase K, their activities were lost (Fig 5). However, treatment of holoenzymes with nuclease resulted in the loss activity of that with P-U protein, whereas there was activity in RNase P-G holoenzyme confirming it to be the activity of RNase P-G protein alone (Fig 5).
RNase P-G protein, RNase P-U protein and RNase P RNA were treated with either micrococcal nuclease (MN) or proteinase K (PK), followed by activity assay using standard conditions. N, untreated sample; MN, treated with micrococcal nuclease; PK, treated with proteinase K; H-G and H-U refer to holoenzymes reconstituted with RNase P-G and RNase P-U proteins, respectively.
Effect of Temperature on the Activity of RNase P Protein Preparations
In order to assess the stability of the two RNase P proteins, they were pre-incubated at 37°, 45°, 50° and 65°C for 30 minutes and subsequently, reconstituted with RNase P RNA to form holoenzymes. While the RNase P-U holoenzyme retained similar pre-tRNA processing activity even after the protein being exposed to high temperatures (Fig 6A), RNase P-G holoenzyme lost considerable activity at 65°C compared to that at 37°C (Fig 6B). This shows that the two protein preparations differ with respect to their stability at higher temperatures.
The two protein preparations, 400 nM each were pre-incubated at indicated temperatures and further used to reconstitute holoenzymes with the 200 nM RNA component. A. RNase P-U holoenzyme. B. RNase P-G holoenzyme. The % product formation in each case was normalized with respect to that at 37°C, which is shown as 100%. Data are plotted as Mean ± SD of three independent observations.
CD Spectroscopy of the M. tuberculosis RNase P Protein Preparations
CD spectroscopy of the two protein preparations was done at 25°C and 65°C (Fig 7A). Both the proteins showed similar structure at 25°C (Fig 7A). However, when exposed to 65°C, RNase P-G protein lost considerable secondary structure compared to that at 25°C, whereas RNase P-U protein did not lose its secondary structure significantly at 65°C (Fig 7A). At 65°C, the CD spectra for both the proteins showed noise beyond 205 nm, so scans have been shown for the 205–250 nm region.
A. Far-UV CD spectra of the two protein preparations from 205–250 nm at different temperatures. B. CD profile of RNase P-U protein and RNase P-G protein within the temperature range of 20–80°C. C. Near-UV CD spectra of RNase P RNA (2 μM), and RNase P-U protein and RNase P-G protein (12 μM each) within 250–320 nm.
Further, we checked the loss of structure with increase in temperature by monitoring change in [θ]222 versus temperature within 20°C to 80°C (Fig 7B). RNase P-G protein lost its secondary structure significantly, whereas RNase P-U protein was not completely denatured even at 80°C (Fig 7B).
To further establish no RNA contamination in RNase P-G protein preparation, near UV-CD spectra of RNase P RNA, and RNase P-U protein and RNase P-G protein were recorded (Fig 7C). RNA showed a typical peak at 265 nm, whereas a much higher concentration of the two proteins did not show any peak in the near UV region (Fig 7C).
Discussion
RNase P has been shown to be essential for survival of M. tuberculosis [26]. The need for new drug targets to counter the evolution of drug-resistance in mycobacterium has emphasized the need for characterization of molecules essential for the survival of M. tuberculosis [27,28]. The detailed characterization of RNase P enzyme of M. tuberculosis described in the current study has implications in exploring this enzyme as a drug target.
The M. tuberculosis RNase P protein component was over-expressed in E. coli where the protein accumulated in inclusion bodies. The protein was purified from inclusion bodies via two protocols that differed in the denaturing agent used to solubilize inclusion bodies and the conditions under which the protein was purified. While RNase P-G protein was solubilized in guanidine, renatured in vitro and purified under native conditions, the RNase P-U protein was solubilized in urea and purified under denaturing conditions, followed by step-wise dialysis to renature the protein. The RNase P-U protein did not show any pre-tRNA processing activity as expected of bacterial RNase P proteins, and was used in our earlier study [21]. However, it was surprising to note that RNase P-G protein cleaved pre-tRNA at low ammonium acetate concentration without the requirement of RNase P RNA. The pre-tRNA processing activities of RNase P-G and RNase P-U holoenzymes, obtained by reconstitution with RNase P RNA, significantly differed under different ionic conditions. The RNase P-G holoenzyme cleaved pre-tRNA in the presence of ammonium acetate upto 500 mM, while the activity of RNase P-G protein was almost completely inhibited at 500 mM ammonium acetate. RNase P-U holoenzyme cleaved pre-tRNA more efficiently than RNase P-G holoenzyme at all concentrations of ammonium acetate used.
It is well known that all RNase P RNAs process pre-tRNA efficiently at high ionic concentrations in vitro [29]. RNase P-G protein cleaved pre-tRNA only at low concentrations of magnesium and ammonium ions, whereas RNase P RNA cleaved pre-tRNA at higher concentrations of magnesium. The differential pre-tRNA processing behaviors by RNase P RNA and RNase P-G protein counters the possibility of an RNA contamination in the protein preparation acquired from the host during the purification. The possibility of RNA contamination was further ruled out by CD spectral analysis. It is also noteworthy that during size-exclusion chromatography, the RNase P-G protein elutes at the size corresponding to 14 kDa as confirmed by molecular weight markers (data not shown), whereas any contaminating co-purifying RNA would have caused RNase P-G protein to elute much earlier owing to bigger mass. Further, the pre-tRNA processing activity of RNase P-G protein was abolished upon its treatment with proteinase K, whereas it was not affected by treatment with micrococcal nuclease confirming that the activity seen is associated with the protein and not due to the presence of any contaminating RNA. To investigate the possibility of any contaminating ribonucleolytic protein in RNase P-G protein preparation, zymogram analysis with yeast tRNA as the substrate was done. Neither RNase P-G protein nor RNase P-U protein cleaved yeast tRNA by themselves or showed any contaminating RNase in the preparation. Moreover, it is evident from the study that the pre-tRNA substrate is cleaved specifically by the P-G protein and not completely digested, as would have been the case with a non-specific ribonuclease contamination. The two protein preparations, as a component of the holoenzyme, differ with respect to their pre-tRNA processing activities at different temperatures, with RNase P-U protein being more thermostable. CD spectroscopy analysis further confirmed that while RNase P-U protein retained much of its secondary structure at 65°C, RNase P-G protein was nearly denatured at 65°C. The CD profiles of the two proteins taken in a temperature range of 20°C to 80°C also showed the loss of structure in RNase P-G protein upon increase in temperature. The loss of structure in case of RNase P-U protein was much less than that of RNase P-G protein. Hence, it is clear that RNase P-U and RNase P-G proteins exist in different conformations which govern their respective properties.
Although catalytic activity has been demonstrated for RNase P RNA of some archaea [30], it has long been thought that the eukaryotic RNase P RNA is inactive without the protein components [31]. However, the RNase P RNA of lower eukaryote Giardia lamblia and human have been shown to be catalytically active without protein subunits also [32]. Earlier studies with human mitochondria and spinach chloroplasts were suggestive of a type of RNase P that does not contain RNA [33,34]. Detailed characterization of human mitochondria and plant organelles has led to the discovery of single proteins denoted as PRORP (PROteinaceous RNase P) that function without an RNA component [35–37]. Various molecular mechanisms, including compartmentalization of intracellular milieu in case of endosymbiosis and genome compaction, have been suggested to be responsible for the evolution of proteinaceous RNase P [38]. Both, the RNA-based and protein-based RNase P facilitate the cleavage at putative phosphodiester bond by bringing metal ions in its vicinity [39,40].
M. tuberculosis has a lifestyle of both a host-restricted symbiont and a pathogen [41]. When M. tuberculosis becomes dormant, protein synthesis is shut down. These dormant mycobacteria restart the protein synthesis machinery when activated by external stimuli, that include oxygen and/or heat shock [42]. Hence, the protein synthesis is required for both actively growing mycobacteria and the dormant bacteria that are undergoing reactivation. It is not clear if the observations made in the current study are seen only in vitro and are non-physiological. However, there is a possibility that under specific circumstances an alternative, catalytically competent, conformation of RNase P protein component of M. tuberculosis gives the pathogen a survival advantage. Greater flexibility at the level of protein synthesis would likely be an advantage to the pathogen for adaptation.
It is interesting to note that mycobacterial RNase P protein can attain a conformation capable of cleaving the pre-tRNA specifically. The capabilities of M. tuberculosis RNase P, to work as an RNA-based as well as a protein-based enzyme under different ionic conditions, is a novel functionality that warrants further investigation.
Author Contributions
Conceived and designed the experiments: AS JKB. Performed the experiments: AS SU AKR. Analyzed the data: AS JKB. Contributed reagents/materials/analysis tools: JKB. Wrote the paper: AS JKB.
References
- 1. Rodnina MV, Wintermeyer W (2011) The ribosome as a molecular machine: the mechanism of tRNA-mRNA movement in translocation. Biochem Soc Trans 39:658–662. pmid:21428957
- 2. Demeshkina N, Jenner L, Yusupova G, Yusupov M (2010) Interactions of the ribosome with mRNA and tRNA. Curr Opin Struct Biol 20:325–332. pmid:20392630
- 3. Bernhardt D, Darnell JE Jr (1969) tRNA synthesis in HeLa cells: a precursor to tRNA and the effects of methionine starvation on tRNA synthesis. J Mol Biol 42:43–56. pmid:4185508
- 4. O'Connor JP, Peebles CL (1991) In vivo pre-tRNA processing in Saccharomyces cerevisiae. Mol Cell Biol 11:425–439. pmid:1986237
- 5. Maraia RJ, Lamichhane TN (2011) 3' processing of eukaryotic precursor tRNAs. Wiley Interdiscip Rev RNA 2:362–375. pmid:21572561
- 6. Morl M, Marchfelder A (2001) The final cut The importance of tRNA 3'-processing. EMBO Rep 2:17–20. pmid:11252717
- 7. Kirsebom LA (2007) RNase P RNA mediated cleavage: substrate recognition and catalysis. Biochimie 89:1183–1194. pmid:17624654
- 8. Evans D, Marquez SM, Pace NR (2006) RNase P: interface of the RNA and protein worlds. Trends Biochem Sci 31:333–341. pmid:16679018
- 9. Esakova O, Krasilnikov AS (2010) Of proteins and RNA: the RNase P/MRP family. RNA 16:1725–1747. pmid:20627997
- 10. Reiter NJ, Osterman A, Torres-Larios A, Swinger KK, Pan T, Mondragon A (2010) Structure of a bacterial ribonuclease P holoenzyme in complex with tRNA. Nature 468:784–789. pmid:21076397
- 11. Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35:849–857. pmid:6197186
- 12. Turrini PC, Loveland JL, Dorit RL (2012) By any other name: heterologous replacement of the Escherichia coli RNase P protein subunit has in vivo fitness consequences. PLoS One 7:e32456. pmid:22448220
- 13. Kazantsev AV, Pace NR (2006) Bacterial RNase P: a new view of an ancient enzyme. Nat Rev Microbiol 4:729–740. pmid:16980936
- 14. Hall TA, Brown JW (2002) Archaeal RNase P has multiple protein subunits homologous to eukaryotic nuclear RNase P proteins. RNA 8:296–306. pmid:12003490
- 15. Xiao S, Scott F, Fierke CA, Engelke DR (2002) Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes. Annu Rev Biochem 71:165–189. pmid:12045094
- 16. Kurz JC, Niranjanakumari S, Fierke CA (1998) Protein component of Bacillus subtilis RNase P specifically enhances the affinity for precursor-tRNAAsp. Biochemistry. 37:2393–2400. pmid:9485387
- 17. Crary SM, Niranjanakumari S, Fierke CA (1998) The protein component of Bacillus subtilis ribonuclease P increases catalytic efficiency by enhancing interactions with the 5' leader sequence of pre-tRNAAsp. Biochemistry 37:9409–9416. pmid:9649323
- 18. Kurz JC, Fierke CA (2002) The affinity of magnesium binding sites in the Bacillus subtilis RNase P x pre-tRNA complex is enhanced by the protein subunit. Biochemistry 41:9545–9558. pmid:12135377
- 19. Westhof E, Wesolowski D, Altman S (1996) Mapping in three dimensions of regions in a catalytic RNA protected from attack by an Fe(II)-EDTA reagent. J Mol Biol 258:600–613. pmid:8636995
- 20. Niranjanakumari S, Stams T, Crary SM, Christianson DW, Fierke CA (1998) Protein component of the ribozyme ribonuclease P alters substrate recognition by directly contacting precursor tRNA. Proc Natl Acad Sci U S A 95:15212–15217. pmid:9860948
- 21. Singh A, Ramteke AK, Afroz T, Batra JK (2016) Insight into the role of histidine in RNR motif of protein component of RNase P of M. tuberculosis in catalysis. IUBMB Life Jan 24.
- 22. Bradford M M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254. pmid:942051
- 23. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685. pmid:5432063
- 24. Krieg PA, Melton DA (1984) Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res 12:7057–7070. pmid:6207484
- 25. Blank A, Sugiyama RH, Dekker CA (1982) Activity staining of nucleolytic enzymes after sodium dodecyl sulfate-polyacrylamide gel electrophoresis: use of aqueous isopropanol to remove detergent from gels. Anal Biochem 120:267–275. pmid:6178316
- 26. Zhang YJ, Ioerger TR, Huttenhower C, Long JE, Sassetti CM, Sacchettini JC, Rubin EJ (2012) Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog 8:e1002946. pmid:23028335
- 27. O'Brien RJ, Nunn PP (2001) The need for new drugs against tuberculosis: Obstacles, opportunities, and next steps. Am J Respir Crit Care Med 163:1055–1058. pmid:11316634
- 28. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K (2011) The challenge of new drug discovery for tuberculosis. Nature 469:483–490. pmid:21270886
- 29. Gossringer M, Helmecke D, Hartmann RK (2012) Characterization of RNase P RNA activity. Methods Mol Biol 848:61–72. pmid:22315063
- 30. Pannucci JA, Haas ES, Hall TA, Harris JK, Brown JW (1999) RNase P RNAs from some Archaea are catalytically active. Proc Natl Acad Sci U S A 96:7803–7808. pmid:10393902
- 31. True HL, Celander DW (1998) Protein components contribute to active site architecture for eukaryotic ribonuclease P. J Biol Chem 273:7193–7196. pmid:9516409
- 32. Kikovska E, Svard SG, Kirsebom LA (2007) Eukaryotic RNase P RNA mediates cleavage in the absence of protein. Proc Natl Acad Sci U S A 104:2062–2067. pmid:17284611
- 33. Wang MJ, Davis NW, Gegenheimer P (1988) Novel mechanisms for maturation of chloroplast transfer RNA precursors. EMBO J 7:1567–1574. pmid:16453848
- 34. Rossmanith W, Karwan RM (1998) Characterization of human mitochondrial RNase P: novel aspects in tRNA processing. Biochem Biophys Res Commun 247:234–241. pmid:9642109
- 35. Holzmann J, Frank P, Loffler E, Bennett KL, Gerner C, Rossmanith W (2008) RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme. Cell 135:462–474. pmid:18984158
- 36. Gobert A, Gutmann B, Taschner A, Gossringer M, Holzmann J, Hartmann RK, Rossmanith W, Giege P (2010) A single Arabidopsis organellar protein has RNase P activity. Nat Struct Mol Biol 17:740–744. pmid:20473316
- 37. Gutmann B, Gobert A, Giege P (2102) PRORP proteins support RNase P activity in both organelles and the nucleus in Arabidopsis. Genes Dev 26:1022–1027.
- 38. Goldfarb KC, Borah S, Cech TR (2012) RNase P branches out from RNP to protein: organelle-triggered diversification? Genes Dev 26:1005–1009. pmid:22588715
- 39. Smith D, Pace NR (1993) Multiple magnesium ions in the ribonuclease P reaction mechanism. Biochemistry 32:5273–5281. pmid:8499432
- 40. Howard MJ, Lim WH, Fierke CA, Koutmos M (2012) Mitochondrial ribonuclease P structure provides insight into the evolution of catalytic strategies for precursor-tRNA 5' processing. Proc Natl Acad Sci U S A 109:16149–16154. pmid:22991464
- 41. Behr MA (2013) Evolution of Mycobacterium tuberculosis. Adv Exp Med Biol 783:81–91. pmid:23468104
- 42. Hu YM, Butcher PD, Sole K, Mitchison DA, Coates AR (1998) Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol Lett 158:139–145. pmid:9453166